AtenololAntihypertensive AgentsHypertensionAdrenergic beta-AntagonistsBlood PressureDiureticsReceptors, Adrenergic, alpha-1HydrochlorothiazideAdrenergic alpha-AntagonistsReceptors, AdrenergicMethyldopaPrazosinSodium Chloride Symporter InhibitorsAmlodipineCalcium Channel BlockersAdrenergic alpha-1 Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAdrenergic AntagonistsAdrenergic alpha-1 Receptor AgonistsAdrenergic alpha-2 Receptor AntagonistsPropranololReceptors, Adrenergic, beta-2Receptors, Adrenergic, alpha-2ClonidinePropanolaminesHydralazineThiazidesDoxazosinReceptors, Adrenergic, beta-3Adrenergic alpha-AgonistsChlorthalidoneReceptors, Adrenergic, betaNorepinephrineYohimbineReceptors, Adrenergic, alphaTrichlormethiazideBlood Pressure Monitoring, AmbulatoryIndapamideNifedipineBlood Pressure DeterminationBenzothiadiazinesAdrenergic alpha-2 Receptor AgonistsDrug Therapy, CombinationLisinoprilRats, Inbred SHRIdazoxanHeart RateAngiotensin II Type 1 Receptor BlockersEnalaprilEpinephrineBendroflumethiazideDihydropyridinesMetoprololCaptoprilDouble-Blind MethodPhenylephrineTetrazolesAchaete-Scute Complex Genome RegionAngiotensin Receptor AntagonistsHypertension, RenalLosartanPulseTreatment OutcomeAdrenergic beta-1 Receptor AntagonistsClinical Trials as TopicPatient ComplianceBenzimidazolesHeroin DependenceRisk FactorsSystolePerindoprilReninDrug PrescriptionsTime FactorsBisoprololLabetalolMinoxidilDihydralazineDrug UtilizationNordefrinNitrendipineFollow-Up StudiesRenin-Angiotensin SystemRats, Sprague-DawleyCardiovascular DiseasesProspective StudiesBiphenyl CompoundsRats, Inbred WKYMedication AdherencePhysician's Practice PatternsDose-Response Relationship, DrugKidney Failure, ChronicPindololHypertension, MalignantHeparitin SulfateReserpineCeliprololCatalogs, Booksellers'AcebutololRandom Allocation